Research Article
Mitochondria-Associated Gene SLC25A32 as a Novel Prognostic and Immunotherapy Biomarker: From Pan-Cancer Multiomics Analysis to Breast Cancer Validation
Figure 4
Proteomic differential analysis of SLC25A32 in pan-cancer. (a) The CPTAC database reveals differences in protein levels in multiple cancers and the corresponding healthy tissues. (b) The PhosphpSitePlus platform counted the types of post-translational modifications of SLC25A32 and the number of citations involved in previous studies. (c) Different tumour sample numbers reveal the frequency of SLC25A32 protein mutation in various cancer types. (d) The UALCAN database compares SLC25A32 protein expression individually in different tumours. ; ; .
(a) |
(b) |
(c) |
(d) |